back to US directory
us clinical guidance

Chest pain of recent onset

US recognition, structured risk assessment and evidence-based testing priorities for acute and stable chest pain.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults with acute or stable chest pain or an anginal equivalent, including pressure, tightness or discomfort in the chest, shoulders, arms, neck, back, upper abdomen or jaw, and presentations dominated by shortness of breath or fatigue. This is a diagnostic pathway, not an ACS-treatment protocol.
sources for this section:AHA/ACC chest pain 2021

The Bottom Line

  • Call symptoms cardiac, possibly cardiac or noncardiac rather than using the misleading term atypical; women and diverse populations remain at risk of underdiagnosis.
  • For acute symptoms, identify life-threatening causes first and use a structured clinical decision pathway with serial high-sensitivity cardiac troponin when available.
  • Estimate coronary and adverse-event risk with an evidence-based protocol; testing is most useful when it is matched to pretest risk and the clinical question.
  • Patients assessed as low risk may not need urgent diagnostic testing, while intermediate- and high-risk presentations need pathway-directed anatomic, functional or invasive evaluation.
  • Include clinically stable patients in decisions about benefits, radiation, downstream procedures, cost and alternatives.
sources for this section:AHA/ACC chest pain 2021

Practical clinical workflow

1
Assess stability and consider ACS, aortic syndrome, pulmonary embolism, pneumothorax, pericardial disease, esophageal rupture and other dangerous causes before routine risk stratification.
2
Obtain a focused symptom history, cardiovascular risk and prior-test history, examination and 12-lead ECG promptly; use serial high-sensitivity troponin in the acute pathway.
3
Apply the institution鈥檚 validated chest-pain clinical decision pathway and classify low, intermediate or high risk.
4
Choose no immediate test, coronary CT angiography, stress imaging or invasive angiography from the risk group, known CAD, age, test availability and contraindications described in the full guideline.
5
Document the working diagnosis, safety-net, follow-up and preventive treatment for known or newly identified coronary disease.
sources for this section:AHA/ACC chest pain 2021

Safety boundaries and escalation

  • Ongoing or recurrent ischemic discomfort, dynamic ECG change, troponin rise, hemodynamic instability, serious arrhythmia, heart failure or another dangerous diagnosis requires emergency escalation.
  • A normal single ECG or early troponin does not by itself exclude ACS; follow the validated serial pathway.
  • Avoid layered or duplicate imaging that will not change management; account for contrast, radiation, renal function, pregnancy and ability to exercise.
  • Do not dismiss symptoms based on sex, age, race, disability, language, anxiety history or a nonclassic location.
sources for this section:AHA/ACC chest pain 2021

Localization

Use a validated US emergency-department or health-system chest-pain pathway and local imaging capability. Insurer authorization matters for elective testing but must not delay emergency evaluation.
sources for this section:AHA/ACC chest pain 2021

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American College of Cardiology and American Heart Association Joint Committee on Clinical Practice Guidelines2021 Guideline for the Evaluation and Diagnosis of Chest PainDOI 10.1161/CIR.0000000000001029 路 published 2021-10-28 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.